ARL4C and colorectal carcinoma: We subsequently generated CRC cell lines with stable overexpression or knockdown of ARL4C, and evaluated their impact on oxaliplatin sensitivity, apoptosis, migration, and invasion through a series of in vitro and in vivo experiments.